Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15034031rdf:typepubmed:Citationlld:pubmed
pubmed-article:15034031lifeskim:mentionsumls-concept:C0014597lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C0111208lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C1332717lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C1706438lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C2698599lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C0022077lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C1155065lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C0085358lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C1413244lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C2698600lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C0031916lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C1947978lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C2348867lld:lifeskim
pubmed-article:15034031lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:15034031pubmed:issue7lld:pubmed
pubmed-article:15034031pubmed:dateCreated2004-3-22lld:pubmed
pubmed-article:15034031pubmed:abstractTextPigment epithelial (PE) cells cultured from the eye possess the novel property of suppressing TCR-dependent activation of T cells in vitro. Iris PE (IPE) cells accomplish this suppression by a direct cell contact mechanism in which B7-2 expressed by the PE cells interacts with CTLA-4 on responding T cells. Because CTLA-4 expression is constitutively expressed on a very small proportion of naive splenic T cells and since exposure of splenic T cells to IPE leads to global T cell suppression, we have inquired into the mechanism by which suppression is achieved. Using splenic T cells and IPE from donor mice with disrupted genes for CD80 (B7-1), CD86 (B7-2), CTLA-4, and/or CD28, we report that B7-2(+) IPE in the presence of anti-CD3 supported selectively the activation of CTLA-4(+) CD8(+) T cells that express their own B7-2 and secrete enhanced amounts of active TGFbeta. By contrast, activation of CTLA-4-negative T cells, especially CD4(+) cells, in these cultures was profoundly suppressed. Because global suppression of T cell activation in these cultures was obtained only when both IPE and T cells possessed B7-2 genes and expressed the costimulators as surface molecules, we propose that T cells activated in the presence of parenchymal cells from the eye (an immune privileged site) express B7-2 in a manner that equips them to suppress bystander T cells. Thus, B7-2 expression on T cells participates in their eventual ability to function as regulators in vitro.lld:pubmed
pubmed-article:15034031pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:languageenglld:pubmed
pubmed-article:15034031pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15034031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15034031pubmed:statusMEDLINElld:pubmed
pubmed-article:15034031pubmed:monthAprlld:pubmed
pubmed-article:15034031pubmed:issn0022-1767lld:pubmed
pubmed-article:15034031pubmed:authorpubmed-author:StreileinJ...lld:pubmed
pubmed-article:15034031pubmed:authorpubmed-author:NgTat FongTFlld:pubmed
pubmed-article:15034031pubmed:authorpubmed-author:Schwartzkopff...lld:pubmed
pubmed-article:15034031pubmed:authorpubmed-author:SugitaSunaoSlld:pubmed
pubmed-article:15034031pubmed:issnTypePrintlld:pubmed
pubmed-article:15034031pubmed:day1lld:pubmed
pubmed-article:15034031pubmed:volume172lld:pubmed
pubmed-article:15034031pubmed:ownerNLMlld:pubmed
pubmed-article:15034031pubmed:authorsCompleteYlld:pubmed
pubmed-article:15034031pubmed:pagination4184-94lld:pubmed
pubmed-article:15034031pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:meshHeadingpubmed-meshheading:15034031...lld:pubmed
pubmed-article:15034031pubmed:year2004lld:pubmed
pubmed-article:15034031pubmed:articleTitleCTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation.lld:pubmed
pubmed-article:15034031pubmed:affiliationSchepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA.lld:pubmed
pubmed-article:15034031pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15034031pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15034031pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
entrez-gene:12477entrezgene:pubmedpubmed-article:15034031lld:entrezgene
entrez-gene:12487entrezgene:pubmedpubmed-article:15034031lld:entrezgene
entrez-gene:12519entrezgene:pubmedpubmed-article:15034031lld:entrezgene
entrez-gene:12524entrezgene:pubmedpubmed-article:15034031lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15034031lld:entrezgene